AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice
Molecular Therapy Advances · 2026-11 · 201884
DOI: 10.1016/j.omta.2026.201884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-11. Verfasst von Svenja Jelinek und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jelinek, S., Bäumges, H., Rothschild-Gronau, C., Beck, H. C., Feiner, R. C., Ilse, M., Müller, K. M., & Lübke, T. (2026). AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice. Molecular Therapy Advances, 201884. https://doi.org/10.1016/j.omta.2026.201884
Vancouver
Jelinek S, Bäumges H, Rothschild-Gronau C, Beck HC, Feiner RC, Ilse M, et al. AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice. Molecular Therapy Advances. 2026:201884. doi:10.1016/j.omta.2026.201884
BibTeX
@article{Jelinek2026,
author = {Jelinek, Svenja and Bäumges, Hannah and Rothschild-Gronau, Claire and Beck, Hans Christian and Feiner, Rebecca Christine and Ilse, Mai-Britt and Müller, Kristian Mark and Lübke, Torben},
title = {AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice},
journal = {Molecular Therapy Advances},
year = {2026},
pages = {201884},
doi = {10.1016/j.omta.2026.201884}
}
EUVIMED